Your browser doesn't support javascript.
loading
Cutaneous sebaceous tumours and Lynch syndrome: long-term follow-up of 60 patients.
Marcoval, J; Talavera-Belmonte, A; Fornons-Servent, R; Bauer-Alonso, A; Penín, R M; Servitje, O.
Afiliación
  • Marcoval J; Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Talavera-Belmonte A; Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Fornons-Servent R; Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Bauer-Alonso A; Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Penín RM; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Servitje O; Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
Clin Exp Dermatol ; 44(5): 506-511, 2019 Jul.
Article en En | MEDLINE | ID: mdl-30430625
BACKGROUND: Sebaceous neoplasms (SN) may appear sporadically in the general population but may also be part of the Muir-Torre variant of Lynch syndrome (MT-LS). There are few studies in southern Europe on the incidence of MT-LS in the population of patients with SN. AIM: To retrospectively review patients with SN and to analyse their clinical features and the incidence of MT-LS. METHODS: Patients with SN diagnosed between 1995 and 2015 were enrolled in the study. The diagnosis of MT-LS was made according to established clinical criteria and, whenever possible, was confirmed by germline mutation analysis. RESULTS: In 60 patients (32 men, 28 women, mean age 69.22 years), 96 SN were diagnosed: 65 adenomas (67.7%), 16 sebaceomas (16.7%) and 15 carcinomas (15.6%). Of the 60 patients, 50 (83.3%) had a single SN and 10 (16.7%) had multiple lesions. Patients diagnosed with MT-LS (12 patients, 20%) were younger (63.25 years vs. 70.71 years), and had a higher incidence of extrafacial SN (4/12 patients, 33.3%), and were significantly (P < 0.001) more likely to have multiple SNs (8/12, 75%) and keratoacanthomas (KAs) (6/12, 50%). CONCLUSION: Our study confirms that all patients with SN should be investigated, as 20% of our patients were diagnosed with MT-LS. The most specific features of SN associated with MT-LS in our study were the presence of multiple lesions and association with KAs.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Adenoma / Adenocarcinoma Sebáceo / Síndrome de Muir-Torre Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Clin Exp Dermatol Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Adenoma / Adenocarcinoma Sebáceo / Síndrome de Muir-Torre Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Clin Exp Dermatol Año: 2019 Tipo del documento: Article